141 related articles for article (PubMed ID: 9663536)
1. Effects of angiotensin converting enzyme inhibition on systemic vascular resistance and vasoconstrictor requirements during hypothermic cardiopulmonary bypass.
Deakin CD; Dalrymple-Hay MJ; Jones P; Monro JL
Eur J Cardiothorac Surg; 1998 May; 13(5):546-50. PubMed ID: 9663536
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass.
Tuman KJ; McCarthy RJ; O'Connor CJ; Holm WE; Ivankovich AD
Anesth Analg; 1995 Mar; 80(3):473-9. PubMed ID: 7864410
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological vasodilatation improves efficiency of rewarming from hypothermic cardiopulmonary bypass.
Deakin CD; Petley GW; Smith D
Br J Anaesth; 1998 Aug; 81(2):147-51. PubMed ID: 9813513
[TBL] [Abstract][Full Text] [Related]
4. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery.
Licker M; Neidhart P; Lustenberger S; Valloton MB; Kalonji T; Fathi M; Morel DR
Anesthesiology; 1996 Apr; 84(4):789-800. PubMed ID: 8638832
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery.
Hasija S; Makhija N; Choudhury M; Hote M; Chauhan S; Kiran U
J Cardiothorac Vasc Anesth; 2010 Apr; 24(2):230-8. PubMed ID: 19875309
[TBL] [Abstract][Full Text] [Related]
6. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements.
Pigott DW; Nagle C; Allman K; Westaby S; Evans RD
Br J Anaesth; 1999 Nov; 83(5):715-20. PubMed ID: 10690132
[TBL] [Abstract][Full Text] [Related]
7. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass.
Maslow AD; Stearns G; Butala P; Schwartz CS; Gough J; Singh AK
Anesth Analg; 2006 Jul; 103(1):2-8, table of contents. PubMed ID: 16790616
[TBL] [Abstract][Full Text] [Related]
8. ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study.
Myles PS; Olenikov I; Bujor MA; Davis BB
Med J Aust; 1993 May; 158(10):675-7. PubMed ID: 8487686
[TBL] [Abstract][Full Text] [Related]
9. Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
Ajuba-Iwuji CC; Puttreddy S; Maxwell BG; Bembea M; Vricella L; Heitmiller E
World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):515-21. PubMed ID: 25324247
[TBL] [Abstract][Full Text] [Related]
10. The effects of two rewarming strategies on heat balance and metabolism after coronary artery bypass surgery with moderate hypothermia.
Hanhela R; Mustonen A; Korhonen I; Salomäki T
Acta Anaesthesiol Scand; 1999 Nov; 43(10):979-88. PubMed ID: 10593459
[TBL] [Abstract][Full Text] [Related]
11. Afterdrop after hypothermic cardiopulmonary bypass: the value of tympanic membrane temperature monitoring.
Pujol A; Fusciardi J; Ingrand P; Baudouin D; Le Guen AF; Menu P
J Cardiothorac Vasc Anesth; 1996 Apr; 10(3):336-41. PubMed ID: 8725413
[TBL] [Abstract][Full Text] [Related]
12. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
[TBL] [Abstract][Full Text] [Related]
13. Postoperative hemodynamics depend on cardiopulmonary bypass temperature: the potential role of endothelin-1.
Tönz M; Mihaljevic T; von Segesser LK; Shaw S; Lüscher TF; Turina M
Eur J Cardiothorac Surg; 1997 Jan; 11(1):157-61. PubMed ID: 9030805
[TBL] [Abstract][Full Text] [Related]
14. Thermal energy balance as a measure of adequate rewarming from hypothermic cardiopulmonary bypass.
Deakin CD; Clewlow F; Pierce JM
J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):388-92. PubMed ID: 10972602
[TBL] [Abstract][Full Text] [Related]
15. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery.
Grigore AM; Grocott HP; Mathew JP; Phillips-Bute B; Stanley TO; Butler A; Landolfo KP; Reves JG; Blumenthal JA; Newman MF;
Anesth Analg; 2002 Jan; 94(1):4-10, table of contents. PubMed ID: 11772792
[TBL] [Abstract][Full Text] [Related]
16. Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass.
Kristof AS; Magder S
Crit Care Med; 1999 Jun; 27(6):1121-7. PubMed ID: 10397216
[TBL] [Abstract][Full Text] [Related]
17. Effect of rewarming speed during hypothermic cardiopulmonary bypass on cerebral pressure-flow relation.
Diephuis JC; Balt J; van Dijk D; Moons KG; Knape JT
Acta Anaesthesiol Scand; 2002 Mar; 46(3):283-8. PubMed ID: 11939919
[TBL] [Abstract][Full Text] [Related]
18. Oxygen consumption in hemodialysis patients undergoing cardiopulmonary bypass.
Karzai W; Priebe HJ
J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):415-7. PubMed ID: 9713729
[TBL] [Abstract][Full Text] [Related]
19. Blood concentrations of enflurane before, during, and after hypothermic cardiopulmonary bypass.
Goucke CR; Hackett LP; Barrett PH; Ilett KF
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):218-23. PubMed ID: 17418735
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide in a temperature dependent regulation of systemic vascular resistance in cardiopulmonary bypass.
Ohata T; Sawa Y; Kadoba K; Kagisaki K; Suzuki K; Matsuda H
Eur J Cardiothorac Surg; 2000 Sep; 18(3):342-7. PubMed ID: 10973545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
